← Open Payments lookup

MINA BARATIFAR: Open Payments

NPI 1922402189 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,414 in 100 payments from 26 companies in 2025. Trend: 2023 $2,667 · 2024 $2,044 · 2025 $2,414

Food & beverage: $2,414
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.5$264
Eisai Inc.5$255
UCB, Inc.9$236
ABBVIE INC.13$231
PFIZER INC.10$185
Novartis Pharmaceuticals Corporation12$172
ARGENX US, INC.5$171
Merz Pharmaceuticals, LLC4$116
Lilly USA, LLC5$102
Vanda Pharmaceuticals Inc.3$76

Products named: AUSTEDO XR, Leqembi, KESIMPTA, VYVGART HYTRULO, NURTEC ODT, Xeomin, BOTOX, Fintepla.

Industry payments across TX — which companies pay providers there.